VTYX
Ventyx Biosciences Inc
NASDAQ: VTYX · HEALTHCARE · BIOTECHNOLOGY
$14.00
+0.00% today
Updated 2026-03-04
Market cap
$1.00B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.49
Dividend yield
—
52W range
$1 – $15
Volume
4.1M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$13.00
-7.14%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy0 Buy8 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-17.56M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-83.75M | $-108.43M | $-192.96M | $-135.12M | $-22.83M |
| EPS | — | — | — | — | $-1.49 |
| Free cash flow | $-38.91M | $-99.05M | $-167.04M | $-131.11M | $-17.56M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Ventyx Biosciences Inc trades at $14.00. Our Smart Value Score of 23/100 indicates the stock is weak.
Frequently asked questions
What is Ventyx Biosciences Inc's stock price?
Ventyx Biosciences Inc (VTYX) trades at $14.00.
Is Ventyx Biosciences Inc overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Ventyx Biosciences Inc (VTYX)?
The analyst target price is $13.00, representing -7.1% downside from the current price of $14.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-0.45%
Beta1.27
50D MA$13.23
200D MA$6.78
Shares out0.07B
Float0.05B
Short ratio—
Avg volume4.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—